Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Streptomyces is a genus of Gram-positive bacteria renowned for its ability to produce a wide range of antibiotics, including some that are critically important in the treatment of pneumonia. The most well-known example is Streptomyces griseus, which produces streptomycin, the first aminoglycoside antibiotic discovered. Streptomycin and other antibiotics derived from Streptomyces spp., such as tetracyclines (from Streptomyces rimosus) and chloramphenicol (from Streptomyces venezuelae), have played foundational roles in the treatment of bacterial pneumonia, particularly before the widespread availability of synthetic antibiotics and modern beta-lactams.

The use of Streptomyces-derived antibiotics is strongly supported by scientific evidence, with numerous clinical studies and decades of medical practice demonstrating their efficacy in treating pneumonia caused by susceptible bacterial pathogens. However, it is important to note that Streptomyces itself (as a living organism or crude preparation) is not administered directly to patients. Instead, purified compounds produced by these bacteria are extracted, characterized, and used as pharmaceutical agents.

In summary, the application of Streptomyces in pneumonia is scientifically validated, but specifically through its antibiotic products rather than direct use of the microorganism. The evidence supporting the use of these antibiotics in pneumonia is robust (rated 4/5 due to evolving resistance and newer agents), and their discovery has had a profound impact on the management of respiratory infections.

More about Streptomyces (unspecified)
More about Pneumonia

Other ingredients used for Pneumonia

Other health conditions supported by Streptomyces (unspecified)

Products containing Streptomyces (unspecified)